Millrace Asset Group, Inc. Myriad Genetics Inc Call Options Transaction History
Millrace Asset Group, Inc.
- $103 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MYGN
# of Institutions
233Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$400 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$218 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$145 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$116 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.13B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...